Vahid Mansouri, MD

Co-founder & Chief Executive Officer (CEO)

Biography

As co-founder of Exir Gene Pharmed and its Chief Executive Officer since 2024, Vahid has led the company’s strategic and organizational development into a focused biotechnology company dedicated to developing high-value gene therapies with the potential to offer new treatment options for diseases that previously had no effective therapies.

Under his leadership, Exir Gene has reached new heights of scientific and organizational performance, establishing itself as a pioneering force in the development of gene therapies for rare diseases. Vahid has sharpened the company’s focus on key therapeutic areas and technology platforms, including CRISPR, antisense oligonucleotides, and viral-vector-based gene therapies, to deliver new medicines for patients with rare but debilitating genetic disorders.

Under his leadership, a culture of innovation, scientific excellence, reputation and performance has become embedded across Exir Gene. In parallel, he is driving the company toward a new phase of digital transformation, with a growing focus on AI-powered platforms, data-driven decision-making and advanced technologies to improve the way genetic medicines are discovered, developed and brought closer to patients.

Vahid currently oversees the development of at least three gene therapy products across Exir Gene’s pipeline, with the company preparing to initiate its first clinical trial in the near future—an important milestone in its transition from research and preclinical development toward clinical-stage biotechnology.

I have always believed that the most meaningful work is the work that turns possibility into impact. What inspires me most about gene therapy is that, for some of the most serious inherited diseases, we now have the opportunity to go beyond managing symptoms and address the disease at its source. At Exir Gene, my goal is to build the science, technology and capabilities needed to turn that promise into real therapies and to bring new hope to patients who have had too few options for too long.

Vahid has built his education and career around a simple belief: we should strive to be the change we wish to see in the world. From medical school to his professional career, he has remained focused on creating meaningful impact, using science, medicine and leadership as tools to improve patients’ lives and help shape a healthier future.

Vahid was a competitive swimmer, and still carries with him the discipline, focus, and resilience the sport demands, finding in swimming a sense of clarity and balance that continues to shape his perspective on life and leadership.

Summary

Portrait of Vahid Mansouri, MD, Chief Executive Officer of Exir Gene Pharmed

Professional Experience

Founder & Chief Executive Officer, Exir Gene Pharmed
2022–Present

Qualified Person, Exir Gene Pharmed
2022–Present

Senior Researcher, Gene Therapy Research Center, Tehran University of Medical Sciences
2019–Present

Education

Master of Business Administration (MBA) in Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2021–2022

Doctor of Medicine (MD), Isfahan University of Medical Sciences, Isfahan, Iran
2012–2019

Scroll to Top